Frequently Asked Questions

Frequently Asked Questions

Why LLS?

The Leukemia & Lymphoma Society (LLS) is the largest voluntary health organization dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients. The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

Since 1949 LLS has been on the forefront of blood cancer advances such as chemotherapies and stem cell transplantation leading the way to the targeted therapies and immunotherapies that are saving thousands of lives today. Cancer does not discriminate. LLS recognizes the need to provide competent care to all communities and patients.

What is Myeloma link?

Myeloma is a blood cancer and the most common form of blood cancer in African Americans. African Americans are twice as likely to develop myeloma. Many new treatments are now available to treat myeloma. To speak with a trained professional for information call 1(844) 955-LINK and to read more on Myeloma visit: https://www.lls.org/disease-information/myeloma.

What is special about this program?

The Leukemia & Lymphoma Society (LLS) is partnering with a wide range of trusted partners within African American communities, including churches, senior centers, and community health centers, in order to:

  • Raise awareness among African Americans about the disparities in myeloma incidence and treatment, signs and symptoms of the disease, and the resources that LLS offers to patients and families dealing with blood cancer;
  • Provide information and resources that will equip African American myeloma patients with the knowledge and tools needed to seek novel, state of the art treatments, including clinical trials, in a timely manner.

African Americans are affected by all types of blood cancers, so why the focus on Myeloma?

Myeloma is the most common blood cancer in African Americans. In addition, African Americans are twice as likely as Whites to develop myeloma. Recent studies show that African Americans are significantly less likely to receive the newest treatments and combination therapies, and more likely to experience treatment delays, including transplant delays.

Myeloma Link is connecting African American Communities to Free Information, Expert Care, and Support.

What other programs does LLS offer

LLS has a vast array of free programs and services. LLS looks to reach all blood cancer patients early in their diagnosis to help connect them with vital information, resources and support. For more information, click here